Cargando…

FOXM1 Inhibition Enhances the Therapeutic Outcome of Lung Cancer Immunotherapy by Modulating PD‐L1 Expression and Cell Proliferation

Programmed death‐ligand 1 (PD‐L1) is a major target to cancer immunotherapy, and anti‐PD‐L1 and anti‐PD‐1 antibody‐mediated immunotherapy are being increasingly used. However, immune checkpoint inhibitors (ICIs) are ineffective in treating large tumors and cause various immune‐related adverse events...

Descripción completa

Detalles Bibliográficos
Autores principales:	Madhi, Hamadi, Lee, Jeon‐Soo, Choi, Young Eun, Li, Yan, Kim, Myoung Hee, Choi, Yongdoo, Goh, Sung‐Ho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561767/ https://www.ncbi.nlm.nih.gov/pubmed/35975458 http://dx.doi.org/10.1002/advs.202202702

Ejemplares similares

FOXM1 Inhibition Enhances the Therapeutic Outcome of Lung Cancer Immunotherapy by Modulating PD‐L1 Expression and Cell Proliferation (Adv. Sci. 29/2022)
por: Madhi, Hamadi, et al.
Publicado: (2022)

FAM188B Expression Is Critical for Cell Growth via FOXM1 Regulation in Lung Cancer
por: Choi, Young Eun, et al.
Publicado: (2020)

FoxM1 is Upregulated in Osteosarcoma and Inhibition of FoxM1 Decreases Osteosarcoma Cell Proliferation, Migration, and Invasion
por: Zhu, Xia, et al.
Publicado: (2020)

MKL1 fuels ROS-induced proliferation of vascular smooth muscle cells by modulating FOXM1 transcription
por: Wu, Teng, et al.
Publicado: (2022)

FOXM1: Functional Roles of FOXM1 in Non-Malignant Diseases
por: Zhang, Zhenwang, et al.
Publicado: (2023)

An update on immunotherapy with PD-1 and PD-L1 blockade
por: Koh, Sung Ae
Publicado: (2021)

Circ-FOXM1 promotes the proliferation, migration and EMT process of osteosarcoma cells through FOXM1-mediated Wnt pathway activation
por: Zhang, Hao, et al.
Publicado: (2022)

MELK-Dependent FOXM1 Phosphorylation is Essential for Proliferation of Glioma Stem Cells
por: Joshi, Kaushal, et al.
Publicado: (2013)

Inactivation of the Akt/FOXM1 Signaling Pathway by Panobinostat Suppresses the Proliferation and Metastasis of Gastric Cancer Cells
por: Lee, Na-Ri, et al.
Publicado: (2021)

CENPE promotes lung adenocarcinoma proliferation and is directly regulated by FOXM1
por: Shan, Lina, et al.
Publicado: (2019)

Redox-Responsive Manganese Dioxide Nanoparticles for Enhanced MR Imaging and Radiotherapy of Lung Cancer
por: Cho, Mi Hyeon, et al.
Publicado: (2017)

CD44v8-10 as a potential theranostic biomarker for targeting disseminated cancer cells in advanced gastric cancer
por: Choi, Eun-Seok, et al.
Publicado: (2017)

Pin1–FOXM1 inhibitors: a potential therapeutic for metastatic melanoma?
por: de Keizer, Peter LJ
Publicado: (2016)

SETD1A Promotes Proliferation of Castration-Resistant Prostate Cancer Cells via FOXM1 Transcription
por: Yang, Liu, et al.
Publicado: (2020)

Intrahepatic inflammatory IgA(+)PD-L1(high) monocytes in hepatocellular carcinoma development and immunotherapy
por: Sung, Pil Soo, et al.
Publicado: (2022)

FOXM1 regulates proliferation, senescence and oxidative stress in keratinocytes and cancer cells
por: Smirnov, Artem, et al.
Publicado: (2016)

Foxm1 regulates cardiomyocyte proliferation in adult zebrafish after cardiac injury
por: Zuppo, Daniel A., et al.
Publicado: (2023)

FOXM1 Modulates Cisplatin Sensitivity by Regulating EXO1 in Ovarian Cancer
por: Zhou, Jinhua, et al.
Publicado: (2014)

Adipose PD-L1 Modulates PD-1/PD-L1 Checkpoint Blockade Immunotherapy Efficacy in Breast Cancer
por: Wu, Bogang, et al.
Publicado: (2018)

Prognostic significance of FOXM1 expression and antitumor effect of FOXM1 inhibition in synovial sarcomas
por: Maekawa, Akira, et al.
Publicado: (2016)

Peptide-based PROTAC degrader of FOXM1 suppresses cancer and decreases GLUT1 and PD-L1 expression
por: Wang, Kun, et al.
Publicado: (2022)

Co-inhibition of ATM and ROCK synergistically improves cell proliferation in replicative senescence by activating FOXM1 and E2F1
por: Yang, Eun Jae, et al.
Publicado: (2022)

Novel Nuclear Partnering Role of EPS8 With FOXM1 in Regulating Cell Proliferation
por: Ngan, Adaline Wan Ling, et al.
Publicado: (2019)

FOXM1-Mediated LINC-ROR Regulates the Proliferation and Sensitivity to Sorafenib in Hepatocellular Carcinoma
por: Zhi, Yingru, et al.
Publicado: (2019)

Tanshinone IIA suppresses gastric cancer cell proliferation and migration by downregulation of FOXM1
por: Yu, Jiao, et al.
Publicado: (2017)

RNF112-mediated FOXM1 ubiquitination suppresses the proliferation and invasion of gastric cancer
por: Zhang, Shengwei, et al.
Publicado: (2023)

Soluble PD-1: Predictive, Prognostic, and Therapeutic Value for Cancer Immunotherapy
por: Khan, Muhammad, et al.
Publicado: (2020)

FOXM1 modulates 5-fluorouracil sensitivity in cholangiocarcinoma through thymidylate synthase (TYMS): implications of FOXM1–TYMS axis uncoupling in 5-FU resistance
por: Intuyod, Kitti, et al.
Publicado: (2018)

FOXM1: A Multifunctional Oncoprotein and Emerging Therapeutic Target in Ovarian Cancer
por: Liu, Cassie, et al.
Publicado: (2021)

Prognostic Significance of Forkhead Box M1 (FOXM1) Expression and Antitumor Effect of FOXM1 Inhibition in Angiosarcoma
por: Ito, Takamichi, et al.
Publicado: (2016)

Exercise sensitizes PD-1/PD-L1 immunotherapy as a hypoxia modulator in the tumor microenvironment of melanoma
por: Yan, Huiyu, et al.
Publicado: (2023)

Twist1 Promotes Gastric Cancer Cell Proliferation through Up-Regulation of FoxM1
por: Qian, Jianxin, et al.
Publicado: (2013)

Downregulation of lncRNA PVT1 inhibits proliferation and migration of mesothelioma cells by targeting FOXM1
por: Fujii, Yutaro, et al.
Publicado: (2022)

The cell-penetrating FOXM1 N-terminus (M1-138) demonstrates potent inhibitory effects on cancer cells by targeting FOXM1 and FOXM1-interacting factor SMAD3
por: Zhang, Zhenwang, et al.
Publicado: (2019)

Honokiol is a FOXM1 antagonist
por: Halasi, Marianna, et al.
Publicado: (2018)

Antenatal Betamethasone Induces Increased Surfactant Proteins and Decreased Foxm1 Expressions in Fetal Rabbit Pups
por: Choi, Yong-Sung, et al.
Publicado: (2021)

Cancer cell line specific co-factors modulate the FOXM1 cistrome
por: Wang, Yue, et al.
Publicado: (2017)

Coordinated activation of c-Src and FOXM1 drives tumor cell proliferation and breast cancer progression
por: Nandi, Ipshita, et al.
Publicado: (2023)

High FOXM1 expression is a prognostic marker for poor clinical outcomes in prostate cancer
por: Kim, Mee Young, et al.
Publicado: (2019)

Emerging Therapeutic Strategies of Different Immunotherapy Approaches Combined with PD-1/PD-L1 Blockade in Cervical Cancer
por: Ge, Yanjun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7s38tsfvf9hrssfl1upf4iv6an